Similar Papers

Paper Title
Journal
Date
Author
A7.06 Low-dose IL-2 therapy in refractory sle: Insights from a phase I/IIA clinical trial
Jy Humrich ... G Riemekasten
Annals of the Rheumatic Diseases | VOL. 75
Jy Humrich, et. al.Jy Humrich ... G Riemekasten
01 Feb 2016
Nonstandard and adjunctive medical therapies for systemic lupus erythematosus
Robert W Mcmurray
Arthritis & Rheumatism | VOL. 45
Robert W McmurrayRobert W Mcmurray
01 Jan 2001
O36 Low-dose IL-2 therapy modulates lymphocyte subsets that are involved in the regulation of germinal-centre reactions in patients with SLE
Jens Y Humrich ... Gabriela Riemekasten
Lupus Science & Medicine | VOL. 7
Jens Y Humrich, et. al.Jens Y Humrich ... Gabriela Riemekasten
01 Mar 2020
06.08 Low-dose il-2 therapy in refractory sle: results from a single centre phase i/iia clinical trial
Jens Y Humrich ... Falk Hiepe
Annals of the Rheumatic Diseases | VOL. 76
Jens Y Humrich, et. al.Jens Y Humrich ... Falk Hiepe
01 Mar 2017
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
Contents
-
Annals of the Rheumatic Diseases | VOL. 83
--
01 Dec 2024
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.